India’s Biological E and the US on October 25 announced the finalization of a financial agreement worth $50 million to expand the capacity of Biological E to produce COVID-19 vaccines.
source https://www.jagranjosh.com/current-affairs/current-affairs-in-short-25-october-2021-1635169860-1